BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18817831)

  • 1. Human leukocyte antigen class I-restricted immunosuppression by human CD8+ regulatory T cells requires CTLA-4-mediated interaction with dendritic cells.
    Jarvis LB; Goodall JC; Gaston JS
    Hum Immunol; 2008 Nov; 69(11):687-95. PubMed ID: 18817831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced suppression of polyclonal CD8
    Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
    J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10/MARCH1-dependent mechanism.
    Chattopadhyay G; Shevach EM
    J Immunol; 2013 Dec; 191(12):5875-84. PubMed ID: 24218453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells.
    Sugita S; Keino H; Futagami Y; Takase H; Mochizuki M; Stein-Streilein J; Streilein JW
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5376-84. PubMed ID: 17122127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity of CD8(+) T cells independently of CD4(+) T cell help.
    McCoy KD; Hermans IF; Fraser JH; Le Gros G; Ronchese F
    J Exp Med; 1999 Apr; 189(7):1157-62. PubMed ID: 10190907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.
    Boasso A; Herbeuval JP; Hardy AW; Winkler C; Shearer GM
    Blood; 2005 Feb; 105(4):1574-81. PubMed ID: 15466932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
    Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B
    PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
    Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity.
    Steinbrink K; Graulich E; Kubsch S; Knop J; Enk AH
    Blood; 2002 Apr; 99(7):2468-76. PubMed ID: 11895781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells.
    Bonini C; Lee SP; Riddell SR; Greenberg PD
    J Immunol; 2001 Apr; 166(8):5250-7. PubMed ID: 11290810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and function of immunosuppressive human and murine CD8+ T cells by transforming growth factor-β and retinoic acid.
    Fleissner D; Frede A; Knott M; Knuschke T; Geffers R; Hansen W; Dobos G; Langhorst J; Buer J; Westendorf AM
    Immunology; 2011 Sep; 134(1):82-92. PubMed ID: 21711349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells.
    Albert ML; Jegathesan M; Darnell RB
    Nat Immunol; 2001 Nov; 2(11):1010-7. PubMed ID: 11590405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4+CD8+ T cells that encounter B7-2+ iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation.
    Sugita S; Ng TF; Schwartzkopff J; Streilein JW
    J Immunol; 2004 Apr; 172(7):4184-94. PubMed ID: 15034031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen, in the presence of TGF-beta, induces up-regulation of FoxP3gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T cell responses.
    Kapp JA; Honjo K; Kapp LM; Goldsmith K; Bucy RP
    J Immunol; 2007 Aug; 179(4):2105-14. PubMed ID: 17675469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of dendritic cells with cancer cells and modulation of surface molecules affect functional properties of CD8+ T cells.
    Seo MJ; Kim GR; Son YM; Yang DC; Chu H; Min TS; Jung ID; Park YM; Han SH; Yun CH
    Mol Immunol; 2011 Sep; 48(15-16):1744-52. PubMed ID: 21632112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adaptor protein Bam32 in human dendritic cells participates in the regulation of MHC class I-induced CD8+ T cell activation.
    Ortner D; Grabher D; Hermann M; Kremmer E; Hofer S; Heufler C
    J Immunol; 2011 Oct; 187(8):3972-8. PubMed ID: 21930970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD25-expressing Th17 cells mediate CD8
    Lang C; Wang J; Chen L
    Exp Cell Res; 2017 Nov; 360(2):384-389. PubMed ID: 28942020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ cytotoxic T-APC stimulate central memory CD8+ T cell responses via acquired peptide-MHC class I complexes and CD80 costimulation, and IL-2 secretion.
    Xia D; Hao S; Xiang J
    J Immunol; 2006 Sep; 177(5):2976-84. PubMed ID: 16920933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.